Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193805-25-000670·Mersana Therapeutics, Inc.
Schedule 13G ownership disclosure
MERSANA THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 59045L106
Event date: 2025-03-31
- Filing-level shares
- 7,614,065.00
- Percent of class
- 6.11%
- Schonfeld Strategic Advisors LLC
Shares: 7,614,065.00 · Class: 6.11%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-25-000670
- Form type
- SCHEDULE 13G
- Filer
- Mersana Therapeutics, Inc.
- CIK
- CIK 1442836
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership